Last reviewed · How we verify

NCT03180320: BESMILE-HF

Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)

Recruiting now NA Last updated 18 May 2025
What this trial tests

NA trial testing BESMILE-HF program in Heart Failure NYHA Class II in 150 participants. Currently enrolling.

Timeline
22 October 2018
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorGuangdong Provincial Hospital of Traditional Chinese Medicine
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment150
Start date22 October 2018
Primary completion31 December 2025
Estimated completion30 June 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Guangdong Provincial Hospital of Traditional Chinese Medicine

Who can join

18 and older, any sex, with Heart Failure NYHA Class II or Heart Failure NYHA Class III. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic heart failure (CHF) is a major and growing public health problem and poses economic burden on the society. There is a need for a safe, equipment-free, low-cost, and easily implemented exercise-based cardiac rehabilitation program for CHF patients in China. Baduanjin exercise, translated as 'eight silken movements', is one of the most common forms of traditional Chinese exercise and it could have value to be integrated into a exercise-based cardiac rehabilitation program for CHF patients, together with education, evaluation and consultancy. Accordingly, the BESMILE-HF program applying the Baduanjin exercise as the central component, has been developed in Guangdong Provincial Hospital of Chinese Medicine which is one of the largest hospitals of Chinese medicine in China. This project is to evaluate the efficacy and acceptability of BESMILE-HF program in patients with CHF in China, and it will be based on a randomized controlled trial and a qualitative study.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of an exercise-based cardiac rehabilitation program "Baduanjin Eight-Silken-Movements with self-efficacy building" for heart failure (BESMILE-HF study): study protocol for a randomized controlled trial.
    Chen X, Jiang W, Lin X, Lundborg CS, et al · · 2018 · cited 16× · PMID 29490680 · DOI 10.1186/s13063-018-2531-9
  2. Feasibility and Preliminary Effects of the BESMILE-HF Program on Chronic Heart Failure Patients: A Pilot Randomized Controlled Trial.
    Chen X, Jiang W, Olson TP, Lundborg CS, et al · · 2021 · cited 8× · PMID 34386535 · DOI 10.3389/fcvm.2021.715207
  3. Traditional <i>Baduanjin</i> exercise through the eyes of patients with chronic heart failure: A qualitative content analysis study.
    Chen X, Jiang W, Salazar M, Zhu H, et al · · 2022 · cited 5× · PMID 36684583 · DOI 10.3389/fcvm.2022.1049036
  4. Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers.
    Sun P, Cen H, Chen S, Chen X, et al · · 2023 · cited 4× · PMID 36894879 · DOI 10.1186/s12872-023-03127-9
  5. Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography.
    Cen H, Chen S, Feng S, Chen X, et al · · 2024 · cited 2× · PMID 39219247 · DOI 10.1002/ehf2.15038
  6. Left Atrial Reservoir Longitudinal Strain is a Resting Marker of Exercise Capacity in Chronic Heart Failure: A Cross-sectional Study
    Sun P, Cen H, Chen S, Chen X, et al · · 2021 · DOI 10.21203/rs.3.rs-991212/v1

Verify or expand the search:

Other recruiting trials for Heart Failure NYHA Class II

Currently open trials in the same condition.

Other Guangdong Provincial Hospital of Traditional Chinese Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03180320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing